BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24162448)

  • 1. A randomized controlled trial of diet and physical activity in BRCA mutation carriers.
    Pasanisi P; Bruno E; Manoukian S; Berrino F
    Fam Cancer; 2014 Jun; 13(2):181-7. PubMed ID: 24162448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families.
    Pasanisi P; Bruno E; Venturelli E; Manoukian S; Barile M; Peissel B; De Giacomi C; Bonanni B; Berrino J; Berrino F
    Fam Cancer; 2011 Sep; 10(3):521-8. PubMed ID: 21455766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
    Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
    Trials; 2016 Jul; 17():368. PubMed ID: 27473440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort.
    Bruno E; Oliverio A; Paradiso A; Daniele A; Tommasi S; Terribile DA; Filippone A; Digennaro M; Pilato B; Danza K; Guarino D; Rossi C; Rossi MM; Venturelli E; Giussani M; Peissel B; Pasanisi P
    Clin Breast Cancer; 2021 Jun; 21(3):e168-e176. PubMed ID: 33357965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers.
    Bruno E; Manoukian S; Venturelli E; Oliverio A; Rovera F; Iula G; Morelli D; Peissel B; Azzolini J; Roveda E; Pasanisi P
    Integr Cancer Ther; 2018 Mar; 17(1):153-160. PubMed ID: 28741383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet quality and BRCA-associated breast cancer risk.
    Nkondjock A; Ghadirian P
    Breast Cancer Res Treat; 2007 Jul; 103(3):361-9. PubMed ID: 17063275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers.
    Pettapiece-Phillips R; Narod SA; Kotsopoulos J
    Cancer Causes Control; 2015 Mar; 26(3):333-44. PubMed ID: 25579073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.
    Nkondjock A; Robidoux A; Paredes Y; Narod SA; Ghadirian P
    Breast Cancer Res Treat; 2006 Aug; 98(3):285-94. PubMed ID: 16541324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dietary Intervention to Lower Serum Levels of IGF-I in
    Pasanisi P; Bruno E; Venturelli E; Morelli D; Oliverio A; Baldassari I; Rovera F; Iula G; Taborelli M; Peissel B; Azzolini J; Manoukian S
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30181513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
    Straub MM; Podoll MB; David SN; Wiesner GL; Desouki MM
    Ann Diagn Pathol; 2018 Oct; 36():28-30. PubMed ID: 30055521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
    Vencken PM; Kriege M; Hooning M; Menke-Pluymers MB; Heemskerk-Gerritsen BA; van Doorn LC; Collée MM; Jager A; van Montfort C; Burger CW; Seynaeve C
    Cancer; 2013 Mar; 119(5):955-62. PubMed ID: 23165859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mediterranean Dietary Intervention in Female Carriers of BRCA Mutations: Results from an Italian Prospective Randomized Controlled Trial.
    Bruno E; Oliverio A; Paradiso AV; Daniele A; Tommasi S; Tufaro A; Terribile DA; Magno S; Filippone A; Venturelli E; Morelli D; Baldassari I; Cravana ML; Manoukian S; Pasanisi P
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322597
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.
    Neuhausen SL; Brummel S; Ding YC; Singer CF; Pfeiler G; Lynch HT; Nathanson KL; Rebbeck TR; Garber JE; Couch F; Weitzel J; Narod SA; Ganz PA; Daly MB; Godwin AK; Isaacs C; Olopade OI; Tomlinson G; Rubinstein WS; Tung N; Blum JL; Gillen DL
    Breast Cancer Res; 2009; 11(5):R76. PubMed ID: 19843326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
    Isselhard A; Töpper M; Berger-Höger B; Steckelberg A; Fischer H; Vitinius F; Beifus K; Köberlein-Neu J; Wiedemann R; Rhiem K; Schmutzler R; Stock S
    Trials; 2020 Jun; 21(1):501. PubMed ID: 32513307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?
    Kim J; Oktay K
    Cancer Causes Control; 2013 Mar; 24(3):421-6. PubMed ID: 23271408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in BRCA mutations carriers: is it time for a "lifestyle" primary prevention?
    Pasanisi P; Bruno E
    Epidemiol Prev; 2018; 42(5-6):369-371. PubMed ID: 30370740
    [No Abstract]   [Full Text] [Related]  

  • 20. Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.
    van Erkelens A; Derks L; Sie AS; Egbers L; Woldringh G; Prins JB; Manders P; Hoogerbrugge N
    J Genet Couns; 2017 Aug; 26(4):785-791. PubMed ID: 27966054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.